Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993112priorityCriticalpatent/ECSP993112A/en
Publication of ECSP993112ApublicationCriticalpatent/ECSP993112A/en
239000002587phosphodiesterase IV inhibitorSubstances0.000abstract1
Landscapes
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Esta invención se refiere a tratar enfermedades pulmonares tales como la enfermedad pulmonar obstructiva crónica o el asma, por administración de un inhibidor de fosfodiesterasa 4 en combinación con un broncodilatador beta-adrenérgico.This invention relates to treating lung diseases such as chronic obstructive pulmonary disease or asthma, by administration of a phosphodiesterase 4 inhibitor in combination with a beta-adrenergic bronchodilator.
ECSP9931121999-08-231999-08-23
THERAPIES TO TREAT LUNG DISEASES
ECSP993112A
(en)
Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
Compound, use of this, process for preparing it, purified single enantiomer, pharmaceutical composition, and, processes for the treatment of chronic bronchitis or chronic obstructive pulmonary disease in a human or animal individual, and for treatment of asthma in a human or animal individual